1. ADAMTS13 in pediatric sepsis: a prognostic biomarker with potential therapeutic implications
- Author
-
Muhammad Said El-Mekkawy, Sara Mahmoud El-Deeb, and Maha Fawzy El-Hanafy
- Subjects
Sepsis ,Pediatric ,ADAMTS13 ,Prognosis ,Mortality ,A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13 ,Pediatrics ,RJ1-570 - Abstract
Abstract Background Growing evidence implicates a pro-thrombotic state, caused by ADAMTS13 deficiency, in sepsis-associated organ dysfunction, but pediatric data is limited. Our purpose was to evaluate association of ADAMTS13 with prognosis of pediatric sepsis. Results This was prospective observational study, conducted on 70 children with sepsis and 18 healthy controls. Patients were classified upon Pediatric Intensive Care Unit (PICU) admission into sepsis, severe sepsis, and septic shock groups. Serum ADAMTS13 was measured within 24 h of admission. The primary outcome was all-cause PICU mortality. ADAMTS13 was lower among patients than controls [median and interquartile range (IQR): 1.30 (0.88–3.13ng/mL) vs. 6.00 (5.55–6.50 ng/mL); p
- Published
- 2023
- Full Text
- View/download PDF